A new study, published in Proceedings of the National Academy of Sciences (PNAS), sheds light on a mechanism underlying Parkinson’s disease and suggests that Tacrolimus — an existing drug that targets the toxic protein interaction explored in the study — could be used as a novel treatment.
Become a Member!
– All SoP monthly magazines
– All NPT magazine archives (63 issues)
– Assorted reading and video courses
– Discounts and access to select webinars and special events
*All pricing in USD.